Healios KK (FRA:6VX) Short Percentage of Float


FRA:6VX Healios KK FRA:6VX
59 GF Score
Price €1.32
GF Value €0.30
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Healios KK Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:6VX vs VRTX, REGN, ALNY: Short Percentage of Float Comparison

For the Biotechnology subindustry, Healios KK's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Healios KK Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Healios KK's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Healios KK's Short Percentage of Float falls into.


FRA:6VX
59GF Score
Healios KK FRA:6VX
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Healios KK (FRA:6VX) Overvalued in 2026?

Based on GuruFocus' analysis, Healios KK stock appears to be overvalued. The current stock price of €1.32 is trading 340% above its estimated GF Value™ of €0.30. GuruFocus considers Healios KK to be Significantly Overvalued.

Key valuation signals for FRA:6VX:

  • Short Percentage of Float:
  • GF Value™: €0.30 vs. price of €1.32 (340% above fair value)
  • GF Score™: 59/100 with 5 warning signs

No single metric tells the full story. See the FRA:6VX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healios KK Business Description

Other Exchanges HLOSF:USA4593:Japan
Address 1-1-2 Yurakucho, Hibiya Mitsui Tower 12Floor, Work Styling, Chiyoda-ku, Tokyo, JPN, 100-0006
Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy. The company develops next-generation cell therapies using a proprietary gene-edited induced pluripotent stem cell (iPSC) platform, with programs targeting immuno-oncology, ophthalmology, liver diseases, ischemic stroke, and acute respiratory distress syndrome.
59GF Score

Get the complete analysis for FRA:6VX

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.32
Price
€0.30
GF Value